Droia Oncology Ventures
Edit

Droia Oncology Ventures

https://droiaventures.com
Last activity: 13.09.2024
Active
Invests in categories: DrugDevelopmentBioTechPlatformScienceTechnologyResearchPersonalMedtechProduct
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. Droia invests in novel science and innovative approaches to bring promising drug candidates to patients, and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. Droia has an in-house team of experts and drug development professionals who follow the portfolio companies closely and provide hands-on support. Droia invests in early financing rounds and incubates new companies. Operating from Luxembourg and Belgium, Droia invests globally.
Portfolio
22
Persons
39
Mentions
3
Location: Belgium, Flemish Brabant, Meise
Employees: 11-50
Founded date: 2011
Investment Type: Venture Capital

Portfolio 22

DateNameWebsiteTotal RaisedLocation
10.01.2024Vaderis Th...vaderis.com--
01.12.2023Hyku Biosc...hykubiosciences.com-United Sta...
02.09.2022Actioactiobio.com-United Sta...
06.08.2022vicinitastx.com-United Sta...
24.07.2022Mahzimahzi.com-Costa Rica
12.12.2021Ambagon Th...ambagontx.com$84.91MUnited Sta...
-Muna Thera...munatherapeutics.com$73MDenmark, C...
-Frontier M...frontiermeds.com$235.5MUnited Sta...
-PACT Pharm...pactpharma.com$75MUnited Sta...
-Vico Thera...vicotx.com$103.35MNetherland...
Show more

Persons 39

DateFirst NameLast NameTitleLinkedInLocation
-PaulineDe ZeeuwAssociate-
-JoBuryInvestment...-
-SergioQuezadaInvestment...-
-DanNomuraInvestment...-
-AnSteenselsScientific...-
-Willem-JanWollantsScientist ...-
-RezHalsePartner-
-KathleenSonckSenior Sci...-
-DieterPetitAssociate-
-LucVerelstFounder &a...-
Show more

Mentions in press and media 3

DateTitleDescription
18.05.2021Hummingbird Bioscience : Raises US$125 Million in Series C FinancingInvestment round led by Novo Holdings, joined by a syndicate of international biotech investors Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision the...
18.05.2021Hummingbird Bioscience Raises US$125 Million in Series C FinancingInvestment round led by Novo Holdings, joined by a syndicate of international biotech investors Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision the...
17.05.2021Hummingbird Bioscience Raises US$125 Million in Series C Financing

Reviews 0

Sign up to leave a review

Sign up Log In